Cambridge Heart Confirms Intent of Recent Registration Statement On Form S-3.Business Editors and Health/Medical Writers BEDFORD, Mass.--(BW HealthWire)--June 20, 2000 Cambridge Heart, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CAMH CAMH Centre for Addiction and Mental Health CAMH Contemporary Arts Museum Houston (Houston, TX) CAMH Comprehensive Accreditation Manual for Hospitals ) today confirmed that its recently filed Registration Statement on Form S-3 covering 2,448,968 shares of its common stock (including shares of common stock issuable upon the exercise of existing warrants) was filed in substitution for two previously outstanding Registration Statements on Form S-2 relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the same shares. The new Registration Statement on Form S-3 was filed for the purpose of consolidating the shares previously registered on the Registration Statements on Form S-2 onto a single Registration Statement. The new Registration Statement on Form S-3 does not constitute a registration of additional outstanding shares of Cambridge Heart common stock, nor does it have the effect of creating any additional overhang Overhang Calculated as stock options granted, plus the remaining options to still be granted, and then divided by the total shares outstanding. Notes: A high percentage for the overhang is usually a bad thing. in the Company's outstanding stock. About Cambridge Heart. Inc. Cambridge Heart is engaged in the research, development and commercialization of products for the noninvasive diagnosis of cardiac disease. Using innovative technologies, the Company is addressing such key problems in cardiac diagnosis as the identification of those at risk of sudden cardiac arrest cardiac arrest n. Abbr. CA A sudden cessation of cardiac function, resulting in loss of effective circulation. Cardiac arrest A condition in which the heart stops functioning. , the early detection of coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. and the prompt and accurate diagnosis of heart attack. The Company, started in 1992, is based in Bedford, Mass., and is traded on the NASDAQ/NMS under the symbol CAMH. Cambridge Heart can be found on the World Wide Web at www.cambridgeheart.com. Statements made in this press release that are not historical facts include forward-looking statements that involve risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include uncertainties associated with regulatory approval processes and other factors that are included in Cambridge Heart's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ending December 31, 1999. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion